ARCHIVES

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Children’s Cancer Research Institute at UT Health Science Center recruits faculty.

December 10, 2004

Test May Identify Predictors For Recurrence Post-Surgery

January 28, 2011

NCI Branch Chiefs, ACCI Join Support For DeVita

June 25, 1981

In Brief: Chabner Says He ”Has No Intention Of Leaving NCI; “Yarbro Named Clinical Indicators Chairman

September 2, 1988

Lymphedema Education Helps Reduce Symptoms, Study Finds

August 28, 2009

ONF Invites Applications for Fatigue Research

April 19, 1996